Related Experiment Video
Updated: May 28, 2026
08:49
Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Machine Learning-Based Identification of Biomarkers for Early-Stage Non-Small Cell Lung Cancer Through Gene
Zorka Szollár1, Fanni Dzsubák1, Ádám Ürmös1
1Hungarian Centre of Excellence for Molecular Medicine (HCEMM), Genome Integrity and DNA Repair Core Group, 6728 Szeged, Hungary.
International Journal of Molecular Sciences
|May 27, 2026
Summary
This study identifies key gene expression differences in early-stage non-small cell lung cancer (NSCLC). Transcriptomic profiling reveals a unique signature for detecting NSCLC and discovering potential biomarkers.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Tumor progression involves DNA mutations and epigenetic changes affecting gene expression.
- Understanding transcriptional regulation is crucial for a complete picture of tumor development.
- Non-small cell lung cancer (NSCLC) requires further investigation into early-stage molecular mechanisms.
Purpose of the Study:
- To identify specific gene expression alterations in early-stage NSCLC.
- To analyze transcriptomic data for differentially expressed genes.
- To validate potential gene expression biomarkers for NSCLC detection.
Main Methods:
- Bioinformatic analysis of RNA-sequencing data from NSCLC samples.
- Validation of identified genes using an independent dataset from The Cancer Genome Atlas.
- Confirmation of gene expression changes in patient-derived tumor tissues.
Main Results:
- A set of differentially expressed genes was identified between NSCLC and normal lung tissues.
- Seven genes were validated, with EFNA4 and TEDC2 upregulated.
- CDC42EP2, STX11, THBD, TMEM88, and GPM6A were found to be downregulated in tumor tissues.
Conclusions:
- A distinct gene expression signature differentiates NSCLC from normal lung tissues at the transcriptional level.
- Transcriptomic profiling shows promise for early-stage cancer detection.
- The identified genes may serve as potential biomarkers for NSCLC.
